New study aims to catch HIV in newborns faster and start better treatment
NCT ID NCT05393193
First seen Feb 28, 2026 · Last updated May 21, 2026 · Updated 14 times
Summary
This study tests a quick HIV test for newborns at high risk of getting HIV from their mothers. Babies who test positive are offered early treatment with the drug dolutegravir. Researchers will follow these babies for 96 weeks to see how well the treatment works and if it is safe. The goal is to make HIV testing and treatment faster and more effective for infants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Botswana Harvard Health Partnership
Gaborone, Botswana
Conditions
Explore the condition pages connected to this study.